About PSA density
PSA density (PSAD) adjusts a man's serum PSA level for the size of his prostate. Because benign prostatic hyperplasia (BPH) causes the prostate to produce more PSA even without cancer, a raised total PSA can simply reflect a larger gland. Dividing PSA by prostate volume gives a value that is less influenced by gland size, which is why PSAD is used most often to help interpret PSA results that fall in the 4 to 10 ng/mL "gray zone."
How the calculation works
- Prostate volume is estimated from three ultrasound or MRI measurements using the ellipsoid (prolate spheroid) formula: volume (mL) = length x width x height x 0.52, with each dimension in centimeters.
- PSA density is then serum PSA (ng/mL) divided by that volume (mL), reported in ng/mL per cc.
- Both the PSA level and the prostate dimensions should come from the same clinical workup, since volume and PSA can each change over time.
Putting the result in context
A PSA density under about 0.10 ng/mL/cc is generally associated with a lower probability of clinically significant prostate cancer, 0.10 to 0.15 falls in an intermediate zone, and 0.15 ng/mL/cc or higher is a commonly cited threshold for considering further evaluation such as MRI or biopsy. These are reference cut-points drawn from the urology literature, not a diagnosis — they are typically weighed alongside PSA velocity, free-to-total PSA ratio, imaging findings, and digital rectal exam results.
When to consult a professional
This calculator performs the standard PSA density arithmetic; it does not diagnose prostate cancer or recommend a course of action. Interpret any PSA density result together with a urologist, who can weigh it against your full history, imaging, and other PSA-derived measures before deciding on next steps such as active surveillance, biopsy, or repeat testing.